In this blog post, we take a look at the latest happenings around the coronavirus outbreak.
Outbreak Spurs Research Activity on Coronavirus
As researchers rush to understand the novel pathogen, there is a spike in the number of published papers since the coronavirus outbreak. As of January 30, at least 54 English-language papers on the coronavirus have been published, over half of which were published in the past seven days. To read more, click here.
Big Pharma Joins the Hunt for a Coronavirus Vaccine
With death tolls from coronavirus outbreak rising, Big Pharma has joined the hunt for the vaccine. GlaxoSmithKline has offered its established pandemic vaccine adjuvant platform technology for vaccine development against the novel coronavirus and Gilead has provided its experimental Ebola therapy for use in a small set of patients in China. Johnson & Johnson, has confirmed that it has already begun working on a potential vaccine. To read more, click here.
Moderna Hopes to Develop Vaccine in Record-Setting Time
The U.S. National Institute of Health has partnered with the Massachusetts biotech company, Moderna, to work on developing an RNA based vaccine for the coronavirus. Moderna’s President, Dr. Stephen Hoge, hopes to develop the vaccine at an unprecedented pace. To read more, click here.
To know more about MaxVal’s Search and Analytics services, click here.